PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST

PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST

Show other versions (1)

<p>Apixaban is a "new" oral anticoagulant, direct Xa factor inhibitor with a good evidence base of the efficacy in the prevention of ischemic stroke in patients with atrial fibrillation. The article is devoted to apixaban use in clinical practice: examination before apixaban administ...

Full description

Bibliographic Details
Main Authors:	D. A. Sychev, I. I. Sinitsina, G. Yu. Zakharova, M. I. Savel'eva, A. V. Ryabova, A. V. Kryukov, A. Yu. Yurovskii
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	новые пероральные антикоагулянты апиксабан клиническая фармакология межлекарственное взаимодействие кровотечения периоперацион-ное ведение
Online Access:	http://www.rpcardio.ru/jour/article/view/154

Similar Items

Practical aspects of apixaban use in clinical practice: continuing the theme
by: S. N. Bel'diev
Published: (2015-11-01)

CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN
by: I. S. Yavelov
Published: (2015-12-01)

COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2015-09-01)

БЕЗОПАСНОСТЬ АНТИКОАГУЛЯНТНОЙ ТЕРАПИИ У БОЛЬНЫХ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ. КАК ОБЕСПЕЧИТЬ ПАЦИЕНТУ ОПТИМАЛЬНОЕ ЛЕЧЕНИЕ?
Published: (2014-12-01)

Elderly patient with atrial fibrillation and coronary risks
by: I. S. Yavelov
Published: (2021-07-01)

PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
by: A. V. Rudakova
Published: (2015-09-01)

Антитромботическая терапия при фибрилляции предсердий: новые пероральные антикоагулянты
Published: (2014-12-01)

Apixaban role in the treatment of venous thromboembolic complications in patients with active cancer
by: E. P. Panchenko
Published: (2020-06-01)

PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST
by: D. A. Sychev, et al.
Published: (2015-09-01)

Pharmacoeconomic evaluation of apixaban use for the treatment and prevention of venous thromboembolism in the general population and patients with oncological diseases
by: A. S. Kolbin, et al.
Published: (2023-03-01)

Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
by: O. V. Shatalova
Published: (2015-12-01)

Main indications for peroral anticoagulants: how to choose an optimal drug
by: I. S. Yavelov
Published: (2018-05-01)

The role of edoxaban in preventing thromboembolic complications in patients with atrial fibrillation
by: O. O. Shakhmatova
Published: (2020-12-01)

NEW ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE
by: E. P. Panchenko
Published: (2015-12-01)

PROPHYLAXIS OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ACTIVE ONCOLOGICAL DISEASE, RECEIVING MEDICAL ANTI-CANCER CHEMOTHERAPY IN OUTPATIENT CONDITIONS. ROLE OF APIXABAN
by: Yu. A. Fedotkina, et al.
Published: (2020-01-01)

Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19
by: V. A. Otdelenov, et al.
Published: (2020-10-01)

Review of the book “Practical issues of rational antibacterial therapy”
by: D. A. Sychev
Published: (2024-02-01)

APIXABAN IN THE TREATMENT OF ATRIAL FIBRILLATION: RANDOMIZED TRIALS AND EVERYDAY CLINICAL PRACTICE
by: O. O. Shakhmatova, et al.
Published: (2017-05-01)

EVALUATION OF EFFICACY AND SAFETY OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN PROSPECTIVE FOLLOW-UP
by: M. V. Khruslov, et al.
Published: (2020-01-01)

EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN THE PREVENTION OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN EVERYDAY CLINICAL PRACTICE: FACTS ABOUT RIVAROXABAN
by: I. S. Yavelov
Published: (2016-07-01)

Перспективы для клинического фармаколога
Published: (2018-06-01)

CONSIDERING QUESTION OF SAFETY OF DIRECT ORAL ANTICOAGULANTS: THE RESULTS OF THE COMPARISON OF APIXABAN AND WARFARIN
by: Igor S. Yavelov
Published: (2018-12-01)

Обзор современных снотворных препаратов
Published: (2018-06-01)

Pharmacology in special populations: extreme age
by: B. K. Romanov, et al.
Published: (2019-10-01)

The era of Belousov Yuri: continuing the tradition. To the 80th birthday
by: P. A. Tatarinov, et al.
Published: (2023-03-01)

A STRATEGY FOR MANAGING A PATIENT WITH ATRIAL FIBRILLATION TO REDUCE THE RISK OF THROMBOEMBOLIC COMPLICATIONS
by: L. I. Kudryavtseva, et al.
Published: (2019-06-01)

Dosage Problems in Children: Well-Known Facts and Unresolved Issues
by: Olga A. Mikhailova, et al.
Published: (2018-10-01)

Anticoagulant therapy in patients with atrial fibrillation and an implanted cardiac resynchronization therapy device
by: M. A. Kirgizova, et al.
Published: (2021-05-01)

ON THE SELECTION OF DRUGS DOSAGE REGIMEN
by: E. N. Bochanova
Published: (2015-09-01)

PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
by: E. D. Kosmacheva, et al.
Published: (2015-09-01)

Balance of efficacy and safety in the prevention of stroke in patients with non-valvular atrial fibrillation: potential of apixaban. Questions and answers
by: I. S. Yavelov
Published: (2015-12-01)

ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY
by: V. A. Sulimov, et al.
Published: (2015-09-01)

NEW PROSPECTS IN THE SECONDARY PREVENTION OF VENOUS THROMBOSIS
by: P. S. Laguta
Published: (2016-07-01)

APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA
by: D. A. Sychev, et al.
Published: (2015-09-01)

Организация системы качественной клинической практики применения антибиотиков в многопрофильном стационаре
Published: (2018-06-01)

Optimization of tactics of the acute varicotrombophlebitis
by: E. P. Krivoschekov, et al.
Published: (2020-12-01)

Pharmacoeconomics as an instrument of clinical pharmacology for optimization of pharmacotherapy (review)
by: O. V. Reshet'ko, et al.
Published: (2018-02-01)

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
by: D. A. Napalkov, et al.
Published: (2015-09-01)

Safety of discontinuation of anticoagulants after venous thromboembolism: whether D-dimer level should be taken into account?
by: I. S. Yavelov
Published: (2023-01-01)

Direct oral anticoagulants for electrical cardioversion
by: A. N. Volovchenko, et al.
Published: (2021-07-01)